What to do when demodex blepharitis treatment options fail

Article

Scott Schachter, OD, discusses what you should do when demodex blepharitis treatment options fail.

Bits and Splits/stock.adobe.com

 

Scott Schachter, OD, discusses what you should do when demodex blepharitis treatment options fail.

Recent Videos
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Dr. Lisa Hornick goes over cosmetic habits and digital eye strain factors in OSD
Laura Periman, MD, discusses a case study in Demodez blepharitis
James Katz, MD, talks Demodex blepharitis treatment options in CIME presentation
Related Content
CT scan Image credit: AdobeStock/AlekseyKhripunkov

Wait, this is not allergies: Case report on carotid-cavernous fistula

Shawna L. Vanderhoof, OD, FAAO
November 18th 2024
Article
Older woman at computer desk rubbing eyes Image credit: ©fizkes - adobe.stock.com

Tear evaporation plays role in dry eye disease

Mile Brujic, OD, FAAO
June 25th 2024
Article
Woman putting on contact lens in mirror Image credit: ©Татьяна Кочкина - adobe.stock.com

Bausch + Lomb launches new INFUSE for Astigmatism contact lenses in the US

Jordana Joy, Associate Editor
June 11th 2024
Article
IPL machine Image credit: ©elenavolf - adobe.stock.com

IPL technology a success at UC Berkeley dry eye clinic

Jordana Joy, Associate Editor
April 26th 2024
Article
Collarettes on eyelashes indicate Demodex mites and Meibomian Gland Disease which can be treated with lotilaner ophthalmic solution under investigation by Tarsus - Image credit: Adobe Stock /ohishiftl

Topline results from Ersa Phase 2a trial revealed by Tarsus

Martin David Harp, Associate Editor, Ophthalmology Times
December 11th 2023
Article
optometrist examines man with ptsosis in eye exam. Image credit: Adobe Stock / Clement C_peopleimages.com.jpg

Don’t overlook blepharoptosis in clinical practice

Mile Brujic, OD, FAAO
December 7th 2023
Article
© 2024 MJH Life Sciences

All rights reserved.